Coupang, Inc. Class A CPNG 深 滬
已收盤 04-02 16:00:00 美东时间
18.95
+0.030
+0.16%
華盛通- 最 高18.98
- 今 開18.445
- 成交量 1393.08万股
- 最 低 18.11
- 昨 收 18.92
- 總市值 346.44亿
- 52周最高 34.075
- 市盈率 靜 169.05
- 換手率 0.76%
- 52周最低 16.74
- 委 比 32.05%
- 總股本 18.28亿
- 歷史最高 69.00
- 量 比 0.68
- 振 幅 4.60%
- 歷史最低 8.98
- 每 手 1
- 風險率 4.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Saudi PIF Eyes SpaceX — But History Offers A Warning
Saudi PIF is reportedly in talks for a $5B SpaceX IPO stake, but its Coupang investment shows IPO hype doesn't guarantee returns.
今天 00:31
Why Is Coupang Stock Gaining Wednesday?
Coupang ($CPNG) jumps 4% premarket on Nvidia partnership. Explore the technical analysis, key support levels, and AI growth strategy.
03-18 18:13
Nebius Group, CytomX Therapeutics, National Storage Affiliates Trust And Other Big Stocks Moving Higher On Monday
Dow Jones index up 500 points; Nebius Group NV shares rise 12.7% on AI agreement with Meta Platforms; several other stocks record gains.
03-16 22:32
Kuehn Law Encourages Investors of Coupang, Inc. to Contact Law Firm
NEW YORK, March 5, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Coupang, Inc. (NYSE: CPNG) breached the...
03-05 23:43
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
Mizuho Maintains Neutral on Coupang, Lowers Price Target to $25
Mizuho analyst James Lee maintains Coupang (NYSE:CPNG) with a Neutral and lowers the price target from $32 to $25.
02-28 01:46
财报速睇 | Coupang, Inc. Class A 2025财年Q4营收88.35亿美元，同比增长10.9%；归母净利润亏损0.26亿美元，由盈转亏
华盛资讯2月27日讯，Coupang, Inc. Class A公布2025财年Q4业绩，公司Q4营收88.35亿美元，同比增长10.9%，归母净利润亏损0.26亿美元，由盈转亏。
02-27 13:37
Coupang shares are trading lower after the company reported worse-than-expected Q4 financial results.
Coupang shares are trading lower after the company reported worse-than-expected...
02-27 05:45
Coupang Q4 Adj. EPS $(0.01) Misses $0.03 Estimate, Sales $8.835B Miss $9.048B Estimate.
Coupang (NYSE:CPNG) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.03 by 134.48 percent. This is a 125 percent decrease over earnings of $0.04 per share from the same
02-27 05:19
